Wednesday, April 16, 2025

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

from Top Health News -- ScienceDaily https://ift.tt/eDV8R6n

No comments:

Post a Comment

Harmful mouth bacteria may trigger Parkinson’s disease

A familiar mouth bacterium best known for causing cavities may also be quietly influencing the brain. Scientists found that when this microb...